Related Experiment Video
Updated: Feb 8, 2026
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Bayesian inference for network meta-regression using multivariate random effects with applications to cholesterol
Hao Li1, Ming-Hui Chen1, Joseph G Ibrahim2
1Department of Statistics, University of Connecticut, Storrs, CT, USA.
Abstract:
Low-density lipoprotein cholesterol (LDL-C) has been identified as a causative factor for atherosclerosis and related coronary heart disease, and as the main target for cholesterol- and lipid-lowering therapy. Statin drugs inhibit cholesterol synthesis in the liver and are typically the first line of therapy to lower elevated levels of LDL-C. On the other hand, a different drug, Ezetimibe, inhibits the absorption of cholesterol by the small intestine and provides a different mechanism of action. Many clinical trials have been carried out on safety and efficacy evaluation of cholesterol lowering drugs. To synthesize the results from different clinical trials, we examine treatment level (aggregate) network meta-data from 29 double-blind, randomized, active, or placebo-controlled statins +/$-$ Ezetimibe clinical trials on adult treatment-naïve patients with primary hypercholesterolemia. In this article, we propose a new approach to carry out Bayesian inference for arm-based network meta-regression. Specifically, we develop a new strategy of grouping the variances of random effects, in which we first formulate possible sets of the groups of the treatments based on their clinical mechanisms of action and then use Bayesian model comparison criteria to select the best set of groups. The proposed approach is especially useful when some treatment arms are involved in only a single trial. In addition, a Markov chain Monte Carlo sampling algorithm is developed to carry out the posterior computations. In particular, the correlation matrix is generated from its full conditional distribution via partial correlations. The proposed methodology is further applied to analyze the network meta-data from 29 trials with 11 treatment arms.
Insights
This study introduces a novel Bayesian approach for network meta-regression, analyzing statins and Ezetimibe trials. The method effectively synthesizes data from cholesterol-lowering drug studies, improving analysis of complex treatment effects.
Area of Science:
- Cardiovascular Medicine
- Biostatistics
- Pharmacology
Background:
- Low-density lipoprotein cholesterol (LDL-C) is a key factor in atherosclerosis and coronary heart disease.
- Statins and Ezetimibe are primary therapies targeting LDL-C through different mechanisms: liver synthesis inhibition and intestinal absorption inhibition, respectively.
- Synthesizing evidence from multiple clinical trials is crucial for evaluating cholesterol-lowering drug efficacy and safety.
Purpose of the Study:
- To propose and validate a new Bayesian inference approach for arm-based network meta-regression.
- To develop a novel strategy for grouping random effects variances based on treatment mechanisms.
- To apply the methodology to analyze aggregate network meta-data from statins +/- Ezetimibe trials.
Main Methods:
- Utilized aggregate data from 29 double-blind, randomized, controlled clinical trials involving statins +/- Ezetimibe.
- Developed a Bayesian meta-regression framework with a new variance grouping strategy for random effects.
- Employed Bayesian model comparison to select optimal treatment group variances.
- Implemented a Markov chain Monte Carlo (MCMC) sampling algorithm for posterior computations.
Main Results:
- The proposed Bayesian meta-regression approach was successfully applied to analyze data from 29 trials with 11 treatment arms.
- The novel variance grouping strategy demonstrated utility, particularly for treatment arms appearing in single trials.
- The methodology facilitated the synthesis of results from diverse cholesterol-lowering drug trials.
Conclusions:
- The developed Bayesian arm-based network meta-regression approach offers a robust method for synthesizing evidence from complex clinical trial networks.
- The variance grouping strategy enhances the analysis of treatment effects, especially in scenarios with limited data per arm.
- This methodology provides valuable insights into the comparative effectiveness of cholesterol-lowering therapies.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
10:44Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline
Published on: December 7, 2021
Related Concept Videos
01:52Regression Toward the Mean
03:28Vapor Pressure Lowering
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:25Multiple Regression
Farmers can use multiple regression to determine the crop yield based on more than one factor, such as water availability, fertilizer, soil properties, etc. Here, the crop yield is the response or dependent variable as it depends on the other independent variables. The analysis requires the construction of a scatter plot...
02:26Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
01:29Cholesterol: Significance and Regulation
Considering cholesterol and...